Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01400373Phase 2Completed

Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study

Role: collaborator

NCT02179060Terminated

Prehospital Resuscitation Intranasal Cooling Effects Seen in MRI of the Brain After Cardiac Arrest

Role: collaborator

NCT02375789Not ApplicableTerminated

Intranasal Cooling for Symptomatic Relief of Migraine

Role: collaborator

NCT01898455Not ApplicableCompleted

Intranasal Cooling for Cluster Headache and Migraine

Role: collaborator

NCT00808236Not ApplicableCompleted

Pre-ROSC Intra-Nasal Cooling Effectiveness

Role: lead

All 5 trials loaded